The role of gastrin in ulcer pathogenesis

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 14, Issue 1, 2000, Pages 13-26

  McColl, Kenneth E L ^a   Gillen, Derek ^a   El Omar, Emad ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Acid; Gastrin; Ulcer

Indexed keywords

GASTRIN; LOXIGLUMIDE;

ATROPHY; CELL HYPERPLASIA; DIET; DUODENUM ULCER; ENTEROCHROMAFFIN CELL; GASTRIN BLOOD LEVEL; GASTRIN CELL; GASTRIN RELEASE; HELICOBACTER PYLORI; HEREDITY; HUMAN; HYPERGASTRINEMIA; INTESTINE METAPLASIA; NEGATIVE FEEDBACK; REVIEW; STOMACH ACID SECRETION; STOMACH ANTRUM; STOMACH MUCOSA; STOMACH PARIETAL CELL; ULCEROGENESIS;

EID: 0034066641     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.1999.0056     Document Type: Article

References (64)

1. Beltinger J, Hildebrand P, Drewe J. Effects of spiroglumide, a gastrin receptor antagonist, on acid secretion in humans. European Journal of Clinical Investigation. 29:1999;153-159.
2. Mulholland G, Ardill J ES, Fillmore D. Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut. 34:1993;757-761.
3. Langhans N, Rindi G, Chiu M. Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology. 112:1997;280-286.
4. Friis-Hansen L, Sundler F, Li Y. Impaired gastric acid secretion in gastrin-deficient mice. American Journal of Physiology. 274:1998;G561-G568.
5. Eissele R, Patberg H, Koop H. Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria. Gastroenterology. 103:1992;1596-1601.
6. Dethloff L A, Robertson D G, Tierney B M. Gastric gland degeneration induced in monkeys by the CCK-B/gastrin receptor antagonist CI-988. Toxicology and Pathology. 25:1997;441-448.
7. Brenna E, Waldum H L. Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: establishment of a dose response relationship. Gut. 33:1992;1303-1306.
8. Eason C T, Spencer A J, Pattison A, Bonner F W. The trophic effects of gastrin on fundic neuroendocrine cells of the rat stomach. Alimentary Pharmacology and Therapeutics. 3:1989;245-251.
9. Nylander A G, Chen D, Lilja I. Enterochromaffin-like cells in rat stomach respond to short-term infusion of high doses of cholecystokinin but not to long-term, sustained, moderate hyperCCKemia caused by continuous cholecystokinin infusion or pancreaticobiliary diversion. Scandinavian Journal of Gastroenterology. 28:1993;73-79.
10. Larsson H, Carlsson E, Hakanson R. Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Gastroenterology. 95:1980;1477-1486.
11. Bordi C, D'Adda T, Azzoni C. Hypergastrinemia and gastric enterochromaffin-like cells. American Journal of Surgical Pathology. 19:1995;S8-S19.
12. Modlin I M, Tang L H. The gastric entrochromaffin-like cell: an enigmatic cellular link. Gastroenterology. 111:1996;783-810.
13. Lamberts R, Creutzfeldt W, Struber H G. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology. 104:1993;1356-1370.
14. Miyazaki Y, Shinomura Y, Tsutsui S. Gastrin induces heparin-binding epidermal growth factor-like growth factor in rat gastro-epithelial cells transfected with gastrin receptor. Gastroenterology. 116:1999;78-90.
15. Peters M N, Feldman M, Walsh J H, Richardson C T. Effect of gastric alkalinization on serum gastrin concentrations in humans. Gastroenterology. 85:1983;35-39.
16. Walsh J H, Richardson C T, Fordtran J S. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. Journal of Clinical Investigation. 55:1975;462-468.
17. Lind T, Cederberg C, Forssel H. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment. Scandinavian Journal of Gastroenterology. 23:1988;1259-1266.
18. Larsson L -I, Goltermann N, de Magistris L. Somatostatin cell processes as pathways for paracrine secretion. Science. 205:1979;1393-1395.
19. Martinez V, Curi A P, Torkian B. High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice. Gastroenterology. 114:1998;1125-1132.
20. Schusdzlarra V, Harris V, Conlon J M, Arimura A. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. Journal of Clinical Investigation. 62:1978;509-518.
21. Holst J J, Peer N Jorgensesn, Rasmussen T N, Schmidt P. Somatostatin restraint of gastrin secretion in pigs revealed by monoclonal antibody immunoneutralization. American Journal of Physiology. 263:1992;G908-G912.
22. Holst J J, Orskov C, Seier-Poulsen S. Somatostatin is an essential paracrine link in acid inhibition of gastrin secretion. Digestion. 51:1992;95-102.
23. Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum, Gastroenterology, 111, 919, 924.
24. Fujita T, Kobayashi S. The cells and hormones of the GEP endocrine system-the current of studies. Fujita T. Gastro-entero-pancreatic Endocrine System. A Cell-biological Approach. 1973;1-16 Igalice Shain, Tokyo.
25. Dragstedt L R. Gastric secretion tests. Gastroenterology. 52:1967;587-590.
26. Lam S K. Pathogenesis and pathophysiology of duodenal ulcer. Clinical Gastroenterology. 13:1984;447-472.
27. Eysselein V E, Kovacs T OG, Kleibeuker J H. Regulation of gastric acid secretion by gastrin in duodenal ulcer patients and healthy subjects. Gastroenterology. 102:1992;1142-1148.
28. Feldman M, Walsh J H. Acid inhibition of sham feeding-stimulated gastrin release and gastric acid secretion: effect of atropine. Gastroenterology. 78:1980;772-776.
29. Jensen S L, Holst J J, Christianssen L A. Effect of intragastric pH on antral gastrin and somatostatin release in anaesthetised, atropinised duodenal ulcer patients and controls. Gut. 28:1987;206-209.
30. Eidt S, Stolte M. Differences between Helicobacter pylori associated gastritis in patients with duodenal ulcer, pyloric ulcer, other gastric ulcer, and gastritis without ulcer. Heliobacter pylori, Gastritis and Peptic Ulcer. 1990;229-236.
31. Schultze V, Hackelsberger A, Gunther T. Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease. Scandinavian Journal of Gastroenterology. 33:1998;137-142.
32. Wyatt J I. Histopathology of gastroduodenal inflammation: the impact of Helicobacter pylori. Histopathology. 26:1995;1-15.
33. El-Omar E, Penman I, Dorrian C A. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut. 34:1993;1060-1065.
34. El-Omar E, Penman I D, Ardill J ES. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology. 109:1995;681-691.
35. McColl K EL, Fullarton G M, Nujumi A M. Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer. Lancet. 1989;499-500.
36. McColl K EL, Fullarton G M, Chittajallu R. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication ofHelicobacter pylori in duodenal ulcer subjects. Scandinavian Journal of Gastroenterology. 26:1991;339-346.
37. Levi S, Beardshall K, Haddad G. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet. 1989;1167-1168.
38. Oderda G, Vaira D, Holton J. Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet. 1989;690-692.
39. Graham D Y, Opekum A, Lew G M. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter pylori(Campylobacter)pylori infection. American Journal of Gastroenterology. 85:1990;394-398.
40. Smith J TL, Pounder R E, Nwokolo C U. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut. 31:1990;522-525.
41. Chittajallu R S, Dorrian C A, Neithercut W D. Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis? Gut. 32:1991;1286-1290.
42. Graham D Y, Go M F, Lew G M. Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing. Scandinavian Journal of Gastroenterology. 28:1993;690-694.
43. Kaneko H, Nakada K, Mitsuma T. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach. Digestive Diseases and Sciences. 37:1992;409-416.
44. Moss S F, Legon S, Bishop A E. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet. 340:1992;930-932.
45. Queiroz D MM, Mendes E N, Rocha G A. Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scandinavian Journal of Gastroenterology. 28:1993;858-864.
46. Sumii M, Summi K, Tari A. Expression of antral gastrin and somatostatin mRNA in Helicobacter pylori -infected subjects. American Journal of Gastroenterology. 89:1994;1515-1519.
47. Tarnasky P R, Kovacs T OG, Sytnik B, Walsh J H. Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation. Digestive Diseases and Sciences. 38:1993;1681-1687.
48. Konturek J W, Konturek S J, Domschke W. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients. Scandinavian Journal of Gastroenterology. 30:1995;738-744.
49. Konturek J W, Gillessen A, Konturek S J, Domschke W. Eradication of H. pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut. 37:1995;482-487.
50. Chittajallu R S, Neithercut W D, Macdonald A MI, McColl K EL. Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations. Gut. 32:1991;21-24.
51. Nujumi A M El, Dorrian C A, Chittajallu R S. Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut. 32:1991;866-870.
52. Koop H, Willemer S, Steinbach F. Influence of chronic drug-induced achlorhydria by substituted benzimadazoles on the endocrine stomach in rats. Gastroenterology. 92:1987;406-413.
53. Crabtree J E, Shallcross T M, Heatley R V, Wyatt J I. Mucosal tumour necrosis factor and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut. 32:1991;1473-1477.
54. Crowe S E, Alvarez L, Dytoc M. Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology. 108:1995;65-74.
55. Haris A W, Gummett P A, Misiewicz J J, Baron J H. Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin. Gut. 38:1996;663-667.
56. Moss S F, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut. 34:1993;888-892.
57. Hamlet A, Olbe L. The influence of Helicobacter pylori on postprandial duodenal acid load and duodenal bulb pH in humans. Gastroenterology. 111:1996;391-400.
58. McColl K EL, Gillen D, Ardill J ES. Effect of antral atrophy on gastric function in H. pylori infection: relevance to progression to pangastritis. Gut. 44:1999;A65.
59. Korman M G, Strickland R G, Hansky J. The functional 'G' cell mass in atrophic gastritis. Gut. 13:1972;349-351.
60. Den Hartog G, Van Der Meer J WM, Jansen J BMJ. Decreased gastrin secretion in patients with late-onset hypogammaglobulinemia. New England Journal of Medicine. 318:1988;1563-1567.
61. Gillen D, El-Omar E M, Wirz A A. The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori -infected subjects. Gastroenterology. 114:1998;50-57.
62. El-Omar E M, Oien K, El-Nujumi A. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 113:1997;15-24.
63. Stolte M, Meining A, Schmitz J M. Changes in Helicobacter pylori -induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 12:1998;247-253.
64. Kuipers E J, Kinkenberg-Knol E C, Havu N. Helicobacter pylori and development of atrophic gastritis during omeprazole maintenance therapy. Gastroenterology. 108:1995;A137.